Raltegravir

Rafivirumab (anti-Rabies virus GP) is an anti-rabies virus monoclonal antibody for the prophylaxis of rabies. Rafivirumab (anti-Rabies virus GP) has neutralizing potency against a broad spectrum of RABV variants. Rafivirumab (anti-Rabies virus GP)

Rafivirumab (anti-Rabies virus GP) is an anti-rabies virus monoclonal antibody for the prophylaxis of rabies. Rafivirumab (anti-Rabies virus GP) has neutralizing potency against a broad spectrum of RABV variants. Rafivirumab (anti-Rabies virus GP)

RALA peptide is a cell-penetrating peptide. RALA peptide can be as non-viral gene delivery vectors.Form:Solid.

RALA peptide is a cell-penetrating peptide. RALA peptide can be as non-viral gene delivery vectors.Form:Solid.

RALA peptide is a cell-penetrating peptide. RALA peptide can be as non-viral gene delivery vectors.Form:Solid.

Biochem/physiol Actions Raltegravir (MK-0518) is an orally active, potent and selective HIV type-1 (HIV-1) integrase inhibitor (IC50 = 2-7 nM: ineffctive against HIV-1 reverse transcriptase or protease) that prevents HIV-1 cellular replication by

Biochem/physiol Actions Raltegravir (MK-0518) is an orally active, potent and selective HIV type-1 (HIV-1) integrase inhibitor (IC50 = 2-7 nM: ineffctive against HIV-1 reverse transcriptase or protease) that prevents HIV-1 cellular replication by

InformationRaltegravir (MK-0518) Raltegravir (MK-0518) is a potent integrase (IN) inhibitor for WT and S217Q PFV IN with IC50 of 90 nM and 40 nM in cell-free assays, respectively. It shows greater than 1000-fold selectivity for HIV-1 IN over several

A potent, selective, and orally bioavailable inhibitor of HIV integrase (IC₅₀ = 15 nM) metabolized primarily by uridine diphosphate glucuronosyltransferase 1A1.

A potent, selective, and orally bioavailable inhibitor of HIV integrase (IC₅₀ = 15 nM) metabolized primarily by uridine diphosphate glucuronosyltransferase 1A1.

A potent, selective, and orally bioavailable inhibitor of HIV integrase (IC₅₀ = 15 nM) metabolized primarily by uridine diphosphate glucuronosyltransferase 1A1.

A potent, selective, and orally bioavailable inhibitor of HIV integrase (IC₅₀ = 15 nM) metabolized primarily by uridine diphosphate glucuronosyltransferase 1A1.